bremelanotide

Product

Heard on podcasts recently

A melanocortin receptor agonist marketed as Vyleesi and approved in the United States for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women.

Rank this week

—
Not in this week’s list

Share of the conversation

—

Reach this week

—

Tone this week

—

Not enough signal yet (fewer than 3 episodes scored).

Share of the conversation

Mentions of bremelanotide per 1,000 mentions of anything, 7-day rolling, all podcasts.

0.0‰0.05‰0.1‰0.15‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Aug 250.11‰2
Sep 10.02‰2
Oct 160.03‰3

Discussed alongside

Names that come up in the same conversations as bremelanotide.

See 3 more with Pro

Embed this

Paste this on your site to show bremelanotide's current trend:

<iframe src="https://podlume.ai/embed/e/bremelanotide" width="360" height="220" style="border:0" loading="lazy" title="bremelanotide on PodLume Trends"></iframe>